Biomarkers in Primary Membranous Nephropathy, A Guide to Precision Medicine

Authors

  • Mohsen Nafar Department of Nephrology, Shahid Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran Author
  • Nooshin Dalili Department of Nephrology, Shahid Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran Author
  • Shiva Samavat Department of Nephrology, Shahid Labbafinejad Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran Author

Abstract

Membranous nephropathy (MN) as one of the most common glomerulonephritis still relies on an invasive procedure of kidney biopsy for precise recognition. Over the recent past years noninvasive methods using wide range of biomarkers have been developed in order to diagnose and estimating the final prognosis of MN. Plasma, urine and tissue are readily accessible specimens for identification of these biomarkers. In order to utilize a single biomarker or a panel of them for detection of a specific entity, many factors should taking into consideration like the accuracy, precision, and validity, accompanying with being available and cost effective. This review is focused on recently developed biomarkers and their application on the diagnosis besides determining the prognosis of MN. The clinical utilities and limitations of each biomarker are discussed in details.

Downloads

Download data is not yet available.

Downloads

Published

2020-09-16

Issue

Section

REVIEW | Kidney Diseases

How to Cite

Biomarkers in Primary Membranous Nephropathy, A Guide to Precision Medicine. (2020). Iranian Journal of Kidney Diseases, 14(5), 335-347. https://www.ijkd.org/index.php/ijkd/article/view/5834

Most read articles by the same author(s)

1 2 3 4 5 > >>